Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era? - Wikidata - wikimedia - TriplyDB

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

http://www.wikidata.org/entity/Q37362731

about

Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.

P2860

Q28543965-2A936A2E-5F31-4E9D-9EA6-50C1083BFA7E

P2860

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

http://www.wikidata.org/entity/Q37362731

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@en

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@nl

type

label

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@en

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@nl

prefLabel

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@en

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@nl

P1433

Q37362731-19826625-5345-4A2B-8A32-9ACC9B90B306

P1476

Q37362731-5DE7009E-F2B0-41BC-B19A-2CF506FD5096

P2093

Q37362731-6DC1C4A8-A2D6-49D8-B40F-4199AA7B1551

Q37362731-83CEFB7E-697E-48C5-888E-9E78CB49A561

Q37362731-842D3B83-E56C-4361-AFBC-3135B4B525DD

Q37362731-98D72251-B16C-4B16-B49A-4B52247E559B

Q37362731-A3A2762F-29EC-4E2E-8E3E-A9E6F6DA430D

Q37362731-A446B52A-FA6C-4860-AF73-9044D963CF36

Q37362731-D124357D-FF75-4A46-9A02-B36F69AEE4E2

Q37362731-F5288622-25D6-4204-9E05-2498D62399F6

P2860

Q37362731-0725A606-BE70-4876-A390-D891880E198C

Q37362731-0D44A4D8-2203-40B8-BE44-4A35D1E4D24C

Q37362731-0FF070F0-89F3-4BC5-9609-B9A7B385866C

Q37362731-153DA8A2-EBF1-4851-BE16-F91480324FD1

Q37362731-19E7BA8C-0D98-446E-BFC8-7F8E39F30103

Q37362731-1D93A3FA-F047-4C37-84F8-94769EF6FDA3

Q37362731-1EAA55CC-4C44-4884-9428-35A1865ADA5C

Q37362731-21A456F8-94A3-4D38-94DF-03872ED8C771

Q37362731-2328F3C1-9B17-45D0-9F25-06412BE85420

Q37362731-293302D8-9A88-4C99-9033-C29D7C27D0A4

P304

Q37362731-897AB6F9-E074-45D8-A8C8-ADBCF994A8B7

P31

Q37362731-E694BC85-F9F9-4C4D-A5BC-9009B4D21309

P356

Q37362731-BA59E006-4BDD-4724-95C9-84AD1C0E8C80

P433

Q37362731-D099998E-7C8F-4D46-BDF8-58D01B97348F

P478

Q37362731-6BB95FA3-7C73-4F6E-9FA9-E8312DB03AFA

P577

Q37362731-170BB792-8240-46CF-9B1A-FBFED36196BE

P698

Q37362731-BDE6D7F6-20AE-4FE1-BC35-121C20F82810

P356

1753944708090573

P1433

Therapeutic advances in cardiovascular disease

P1476

Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?

@en

P2093

Ana Viana

http://www.w3.org/2001/XMLSchema#string

Angel Sanchez-Recalde

http://www.w3.org/2001/XMLSchema#string

Esteban Lopez de Sá

http://www.w3.org/2001/XMLSchema#string

Guillermo Galeote

http://www.w3.org/2001/XMLSchema#string

Jose López-Sendón

http://www.w3.org/2001/XMLSchema#string

Luis Calvo

http://www.w3.org/2001/XMLSchema#string

Raul Moreno

http://www.w3.org/2001/XMLSchema#string

Santiago Jimenez-Valero

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Atherosclerosis — An Inflammatory Disease

Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interven

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

Vascular responses to drug eluting stents: importance of delayed healing

Coronary in-stent restenosis: current status and future strategies.

Overview of therapies for prevention of restenosis after coronary interventions.

P304

137-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753944708090573

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19124417

http://www.w3.org/2001/XMLSchema#string